Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study
Nicola Pugliese(Humanitas University), Alessio Aghemo, Daniela Maggi(Sapienza University of Rome), Antonio Capogreco(Humanitas University), Arianna Dal Buono(Humanitas University), Ana Lleò(Humanitas University), Pier Maria Battezzati(University of Milan), Alessia Giorgini(Università Cattolica del Sacro Cuore), Clara Dibenedetto, Massimo Zuin(AOL (United States)), A. De Santis(Sapienza University of Rome), Sara Monico(University of Milan), Rossella Meli(IRCCS Humanitas Research Hospital), Federica Lubrano Lobianco(Sapienza University of Rome)
Cited by 6
Related Papers
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394